
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and...
Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and...